Riehen, Switzerland

Amanda Lee Dupont

This inventor holds 1 USPTO granted patent. Top assignee: Hoffmann-La Roche Inc.. Active years: 2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Amanda Lee Dupont. Retrieved from https://idiyas.com/inventor/amanda-lee-dupont

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 10.0

ph-index = 1


Company Filing History:


Years Active: 2026

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Amanda Lee Dupont: Innovator in Medicinal Chemistry

Introduction

Amanda Lee Dupont is a prominent inventor based in Riehen, Switzerland. She has made significant contributions to the field of medicinal chemistry, particularly in the development of innovative compounds for therapeutic use. Her work is characterized by a commitment to advancing medical science through her inventive spirit.

Latest Patents

Amanda holds a patent for her invention titled "Alkynyl-(heteroaryl)-carboxamide HCN1 inhibitors." This patent describes compounds of formula I, wherein R, Ror Rare are defined as specified in the documentation. The invention also encompasses pharmaceutically acceptable salts of these compounds. Furthermore, it addresses the manufacture of these compounds, pharmaceutical compositions that include them, and their application as medicaments.

Career Highlights

Amanda is currently employed at Hoffmann-La Roche Inc., a leading global healthcare company. Her role involves extensive research and development in the pharmaceutical sector, where she applies her expertise to create innovative solutions for health challenges.

Collaborations

Amanda has collaborated with notable colleagues, including Eva Katrin Harde and Bjoern Bartels. These partnerships have fostered a dynamic research environment, enhancing the potential for groundbreaking discoveries in their field.

Conclusion

Amanda Lee Dupont exemplifies the spirit of innovation in medicinal chemistry. Her contributions through patents and collaborations continue to impact the pharmaceutical industry positively.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…